Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 6267
  • Home
  • Print this page
  • Email this page
This article has been cited by
1Short-Term Effects of Early Switching to Ranibizumab or Aflibercept in Diabetic Macular Edema Cases With Non-Response to Bevacizumab
Mohammed Ashraf,Ahmed A. R. Souka,Hassan ElKayal
Ophthalmic Surgery, Lasers and Imaging Retina.2017;48(3)230
[DOI]
2A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema
Ye He,Xin-jun Ren,Bo-jie Hu,Wai-Ching Lam,Xiao-rong Li
BMC Ophthalmology.2018;18(1)230
[DOI]
3TREATMENT OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR–RESISTANT DIABETIC MACULAR EDEMA WITH DEXAMETHASONE INTRAVITREAL IMPLANT
Ratimir Lazic,Marko Lukic,Ivan Boras,Natasa Draca,Marko Vlasic,Nikica Gabric,Zoran Tomic
Retina.2014;34(4)719
[DOI]
4A cost-effectiveness study of dexamethasone implants in macular edema
V. Lozano López,M. Serrano García,C. Mantolán Sarmiento,A. Pareja Ríos,M.J. Losada Castillo,L. Cordovés Dorta,E. Quijada Fumero,T. Virgós Aller,M. Bullejos Molina
Archivos de la Sociedad Española de Oftalmología (English Edition).2015;90(1)14
[DOI]
5Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema
Verónica Castro-Navarro,Enrique Cervera-Taulet,Catalina Navarro-Palop,Clara Monferrer-Adsuara,Laura Hernández-Bel,Javier Montero-Hernández
BMC Ophthalmology.2019;19(1)14
[DOI]
6Respuestas tisulares y vasculares en retinopatía hipertensiva con anticuerpos monoclonales como terapia antiangiogénica
Sandra Johanna Garzón Parra,Adriana María Bonilla Hernández,Andrés Felipe Pulido Ladino,Edouard Lafosse
Ciencia & Tecnología para la Salud Visual y Ocular.2013;11(2)79
[DOI]
7The Sustained-Release Dexamethasone Implant: Expanding Indications in Vitreoretinal Disease
K. G. Kapoor,M. G. Wagner,A. L. Wagner
Seminars in Ophthalmology.2015;30(5-6)475
[DOI]
8Resultados coste-efectividad del implante de dexametasona en edema macular
V. Lozano López,M. Serrano García,C. Mantolán Sarmiento,A. Pareja Ríos,M.J. Losada Castillo,L. Cordovés Dorta,E. Quijada Fumero,T. Virgós Aller,M. Bullejos Molina
Archivos de la Sociedad Española de Oftalmología.2015;90(1)14
[DOI]
9A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY
Raj K. Maturi,Laura Bleau,Jeffrey Saunders,Mohamed Mubasher,Michael W. Stewart
Retina.2015;35(8)1604
[DOI]
10Intravitreal Injection of Ozurdex® Implant in Patients with Persistent Diabetic Macular Edema, with Six-Month Follow-Up
Fernanda Pacella,Adriana Francesca Ferraresi,Paolo Turchetti,Tommaso Lenzi,Rosalia Giustolisi,Andrea Bottone,Valeria Fameli,Maria Rosaria Romano,Elena Pacella
Ophthalmology and Eye Diseases.2016;8(8)OED.S38028
[DOI]
11Intravitreal dexamethasone implant Ozurdex in the treatment of diabetic macular edema in patients not previously treated with any intravitreal drug: a prospective 12-month follow-up study
Marc Menezo,Manuel Roca,Víctor Menezo,Isabel Pascual
Current Medical Research and Opinion.2019;35(12)2111
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal